SGMT
SGMT
NASDAQ · Biotechnology

Sagimet Biosciences Inc-A

$4.89
-0.22 (-4.31%)
As of Mar 29, 10:36 PM ET ·
Financial Highlights (FY 2025)
Revenue
28.61M
Net Income
3.39M
Gross Margin
62.8%
Profit Margin
11.8%
Rev Growth
+24.7%
D/E Ratio
0.41
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 62.8% 62.8% 62.8%
Operating Margin 18.1% 15.2% 17.1%
Profit Margin 11.8% 14.2% 14.4%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 28.61M 29.26M 29.39M
Gross Profit 17.97M 18.38M 18.46M
Operating Income 5.18M 4.46M 5.03M
Net Income 3.39M 4.16M 4.24M
Gross Margin 62.8% 62.8% 62.8%
Operating Margin 18.1% 15.2% 17.1%
Profit Margin 11.8% 14.2% 14.4%
Rev Growth +24.7% +14.4% -5.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 26.81M 31.18M 23.95M
Total Equity 64.77M 65.54M 66.31M
D/E Ratio 0.41 0.48 0.36
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 5.59M 5.60M 5.84M
Free Cash Flow 4.74M 2.94M 4.50M